Gerresheimer AG (ETR:GXI – Get Free Report) shares shot up 4.5% on Friday . The company traded as high as €50.60 ($58.84) and last traded at €50.50 ($58.72). 778,144 shares changed hands during trading, an increase of 452% from the average session volume of 140,925 shares. The stock had previously closed at €48.34 ($56.21).
Gerresheimer Price Performance
The stock has a market cap of $1.68 billion, a P/E ratio of 14.68, a price-to-earnings-growth ratio of 0.82 and a beta of 0.94. The business’s 50 day moving average price is €53.21 and its two-hundred day moving average price is €63.49. The company has a current ratio of 0.80, a quick ratio of 0.40 and a debt-to-equity ratio of 87.94.
About Gerresheimer
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
Read More
- Five stocks we like better than Gerresheimer
- 3 Warren Buffett Stocks to Buy Now
- Power Solutions International Poised for 75% Upside
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Why Wall Street Is Betting on These 3 Comeback Stocks
- Differences Between Momentum Investing and Long Term Investing
- Smart Investors Are Watching These 3 Undervalued Stocks
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.